Sagimet Announces Positive 52-Week Data from License Partner Ascletis’ Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 (Denifanstat) Tablets in ...

“The topline results from Ascletis’ Phase 3 open-label acne trial in China build additional confidence in the clinical potential of FASN inhibition in acne,” said David Happel, Chief Executive Officer ...

Sagimet Biosciences Inc.: Sagimet Announces Positive 52-Week Data from License Partner Ascletis' Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 ...

Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...

Nightfall expands data protection with AI Browser Security for browsers, endpoints and SaaS

Cloud data protection startup Nightfall today announced the launch of its AI Browser Security solution, a new solution ...
GitHub

Me-HDi/Mehdis-mcp-context-forge

A flexible feature-rich FastAPI-based gateway for the Model Context Protocol (MCP) that unifies and federates tools, resources, prompts, servers and peer gateways, wraps any REST API as MCP-compliant ...
GitHub

Revive Adserver REST API Plugin

A comprehensive REST API plugin for Revive Adserver that provides RESTful endpoints for managing campaigns, banners, zones, targeting, and statistics. Features a complete API token management system ...

Adaptiva Named a Leader in the 2026 Gartner(R) Magic Quadrant(TM) for Endpoint Management Tools

Adaptiva, the Autonomous Endpoint Management (AEM) company, today announced it has been named a Leader in the 2026 Gartner(R) Magic Quadrant(TM) for Endpoint Management Tools. Recognized for both ...